Fulgent Genetics Pre-Tax Profit Margin 2015-2024 | FLGT
Fulgent Genetics pre-tax profit margin from 2015 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Fulgent Genetics Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2024-12-31 |
$0.28B |
$-0.05B |
-18.37% |
2024-09-30 |
$0.28B |
$-0.19B |
-67.99% |
2024-06-30 |
$0.29B |
$-0.16B |
-56.01% |
2024-03-31 |
$0.29B |
$-0.17B |
-57.99% |
2023-12-31 |
$0.29B |
$-0.17B |
-60.00% |
2023-09-30 |
$0.29B |
$-0.06B |
-21.60% |
2023-06-30 |
$0.31B |
$-0.07B |
-21.75% |
2023-03-31 |
$0.37B |
$-0.04B |
-10.41% |
2022-12-31 |
$0.62B |
$0.19B |
29.89% |
2022-09-30 |
$0.80B |
$0.37B |
45.95% |
2022-06-30 |
$0.93B |
$0.53B |
56.97% |
2022-03-31 |
$0.95B |
$0.61B |
64.26% |
2021-12-31 |
$0.99B |
$0.68B |
68.28% |
2021-09-30 |
$1.04B |
$0.75B |
72.68% |
2021-06-30 |
$0.91B |
$0.66B |
72.20% |
2021-03-31 |
$0.77B |
$0.56B |
72.45% |
2020-12-31 |
$0.42B |
$0.29B |
68.96% |
2020-09-30 |
$0.14B |
$0.07B |
48.15% |
2020-06-30 |
$0.04B |
$0.00B |
6.98% |
2020-03-31 |
$0.03B |
0 |
0.00% |
2019-12-31 |
$0.03B |
0 |
0.00% |
2019-09-30 |
$0.03B |
$0.00B |
-3.45% |
2019-06-30 |
$0.03B |
$0.00B |
-16.00% |
2019-03-31 |
$0.02B |
$-0.01B |
-22.73% |
2018-12-31 |
$0.02B |
$-0.01B |
-22.73% |
2018-09-30 |
$0.02B |
$-0.01B |
-30.00% |
2018-06-30 |
$0.02B |
$-0.01B |
-31.58% |
2018-03-31 |
$0.02B |
$-0.01B |
-26.32% |
2017-12-31 |
$0.02B |
$0.00B |
-15.79% |
2017-09-30 |
$0.02B |
0 |
0.00% |
2017-06-30 |
$0.02B |
0 |
0.00% |
2017-03-31 |
$0.02B |
$0.00B |
-20.00% |
2016-12-31 |
$0.02B |
$-0.01B |
-27.78% |
2016-06-30 |
$0.01B |
$0.00B |
-40.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MEDICAL INFO SYS |
$0.532B |
$0.283B |
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
|